Many previous pharmacogenomic studies in individuals with HIV/AIDS receiving EFV-containing treatment have reported that some patients have EFV plasma concentrations unexplained by the CYP2B6*6 and *18 variants. The gene discussed is CYP2B6; the disease is AIDS.